Target intelligence / Profile preview

IGBP1 pseudogene 1 (IGBP1P1)

Target
IGBP1P1
Molecular classification
Other
01

Overview

**IGBP1 pseudogene 1 (IGBP1P1)** is classified as a pseudogene—an inactive DNA sequence similar to the functional IGBP1 gene but generally considered non-coding and not expressed as a functional protein in humans. Pseudogenes have traditionally been thought to lack biological activity, though some may have regulatory roles at the RNA level; however, there are no documented roles, functions, or disease associations specifically for IGBP1P1. It is not regarded as a therapeutic target and does not have relevant interactions with drugs or established safety considerations[7][8]. **Key points:** - **IGBP1P1 is a pseudogene, not a protein-coding gene**[7]. - It does not encode a protein and is not a recognized therapeutic target. - There is no evidence of biological or pathological function or use as a biomarker for IGBP1P1 specifically. - Information about drugs, mechanisms of action, and safety is not applicable. **Clarification:** If you meant the active gene **IGBP1 (Immunoglobulin-binding protein 1)**: - It is a protein-coding gene involved in B-cell receptor signaling, has some documented disease associations and biomarker relevance (notably in lupus nephritis), and may be a drug target candidate in signaling/modulatory pathways[1][2][3]. - *IGBP1P1*, as a **pseudogene**, should not be confused with the active IGBP1 gene. **Summary:** IGBP1P1 is a non-protein-coding pseudogene, **not suitable** as a drug target or biomarker, and information about its biology or pharmacology is not applicable[7].

Beyond the preview

Go deeper on IGBP1 pseudogene 1 (IGBP1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IGBP1 pseudogene 1 (IGBP1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call